Comprehensive Safety Monitoring Across the mRNA Product Lifecycle from Clinical Development to Post-Marketing

• Understand best practices of safety monitoring during clinical trials to ensure robust safety oversight
• Learn how post-marketing studies and close interaction with health authorities shape ongoing patient safety and regulatory compliance.

Speakers:

Kirsten Nespithal

Director Safety Lead Risk Management

BioNTech